Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1130 result(s) found, displaying 801 to 825

  • AusPAR: Crizotinib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Crizotinib

  • AusPAR: Deferasirox

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Deferasirox

  • AusPAR: Aminolevulinic acid HCl

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Aminolevulinic acid HCl

  • AusPAR: Catumaxomab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Catumaxomab

  • AusPAR: Denosumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Denosumab

  • AusPAR: Adalimumab

    Australian public assessment report (AusPar)
    Australian public assessment report for Adalimumab

  • AusPAR: Imatinib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Imatinib

  • AusPAR: Tocilizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Tocilizumab

  • AusPAR: Levonorgestrel

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Levonorgestrel

  • AusPAR: Alemtuzumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Alemtuzamab (rch)

  • AusPAR: Ruxolitinib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ruxolitinib

  • AusPAR: Regorafenib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Regorafenib

  • AusPAR: Mirabegron

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Mirabegron

  • AusPAR: Alogliptin (as benzoate)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Alogliptin (as benzoate)

  • AusPAR: Dabrafenib mesilate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Dabrafenib mesilate

  • AusPAR: Eltrombopag olamine

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Eltrombopag olamine

  • AusPAR: Fentanyl citrate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Fentanyl citrate